tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

IOBT Stock Latest News

IO Biotech Receives Nasdaq Notice for Bid Price Noncompliance
Company AnnouncementsIO Biotech Receives Nasdaq Notice for Bid Price Noncompliance
7d ago
8K
IOBT
IO Biotech publishes MM1636 trial results in Nature Communications
PremiumThe Fly
IO Biotech publishes MM1636 trial results in Nature Communications
11d ago
IOBT
IO Biotech Announces Resignation of Chief Accounting Officer
PremiumCompany Announcements
IO Biotech Announces Resignation of Chief Accounting Officer
1M ago
8K
IOBT
IO Biotech’s Q3 2025: Progress in Cancer Vaccine Trials
PremiumCompany Announcements
IO Biotech’s Q3 2025: Progress in Cancer Vaccine Trials
1M ago
IOBT
IO Biotech Presents at Jefferies Global Healthcare Conference
PremiumCompany Announcements
IO Biotech Presents at Jefferies Global Healthcare Conference
1M ago
8K
IOBT
IO Biotech’s Hold Rating Amid Financial and Regulatory Uncertainty
PremiumRatingsIO Biotech’s Hold Rating Amid Financial and Regulatory Uncertainty
1M ago
IOBT
IO Biotech reports Q3 EPS (13c) vs (36c) last year
Premium
The Fly
IO Biotech reports Q3 EPS (13c) vs (36c) last year
1M ago
IOBT
IO Biotech presents pre-clinical data on IO112, IO170
Premium
The Fly
IO Biotech presents pre-clinical data on IO112, IO170
2M ago
IOBT
IO Biotech price target lowered to $3 from $10 at Piper Sandler
PremiumThe Fly
IO Biotech price target lowered to $3 from $10 at Piper Sandler
2M ago
IOBT
IO Biotech reports expanded Cylembio results
PremiumThe Fly
IO Biotech reports expanded Cylembio results
2M ago
MRK
IOBT
IO Biotech downgraded to Equal Weight from Overweight at Morgan Stanley
PremiumThe Fly
IO Biotech downgraded to Equal Weight from Overweight at Morgan Stanley
3M ago
IOBT
Hold Rating for IO Biotech Amid Regulatory and Financial Challenges
PremiumRatings
Hold Rating for IO Biotech Amid Regulatory and Financial Challenges
3M ago
IOBT
IO Biotech downgraded to Hold from Buy at TD Cowen
PremiumThe FlyIO Biotech downgraded to Hold from Buy at TD Cowen
3M ago
IOBT
IO Biotech downgraded to Neutral from Buy at H.C. Wainwright
Premium
The Fly
IO Biotech downgraded to Neutral from Buy at H.C. Wainwright
3M ago
IOBT
H.C. Wainwright downgrades IO Biotech after FDA recommends another Phase 3 trial
Premium
The Fly
H.C. Wainwright downgrades IO Biotech after FDA recommends another Phase 3 trial
3M ago
IOBT
FDA Recommends Against IO Biotech’s Cylembio Application
PremiumCompany Announcements
FDA Recommends Against IO Biotech’s Cylembio Application
3M ago
8K
IOBT
IO Biotech says FDA reccomends not submitting BLA based on IOB-013 trial data
PremiumThe Fly
IO Biotech says FDA reccomends not submitting BLA based on IOB-013 trial data
3M ago
IOBT
IO Biotech implements plan to conserve capital, 50% reduction in full-time staff
PremiumThe Fly
IO Biotech implements plan to conserve capital, 50% reduction in full-time staff
3M ago
IOBT
IO Biotech Reports Q2 2025 Financial Results
PremiumCompany Announcements
IO Biotech Reports Q2 2025 Financial Results
4M ago
IOBT
IO Biotech’s Cylembio Shows Promise Despite Missed Endpoint, Buy Rating Affirmed
PremiumRatingsIO Biotech’s Cylembio Shows Promise Despite Missed Endpoint, Buy Rating Affirmed
4M ago
IOBT
Promising Phase 3 Results and Strategic FDA Engagement Bolster Buy Rating for IO Biotech
Premium
Ratings
Promising Phase 3 Results and Strategic FDA Engagement Bolster Buy Rating for IO Biotech
5M ago
IOBT
IO Biotech Reveals Phase 3 Trial Results for Cylembio
Premium
Company Announcements
IO Biotech Reveals Phase 3 Trial Results for Cylembio
5M ago
8K
IOBT

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >